UK gets social media presence

The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation there, issued “informal guidance” on digital communications, and while it's more than FDA has offered, it's not much to go on.
The guidance, which takes the form of a Q&A, is mainly an interpretation of the industry's Code of Practice applied to social media and the internet. Short version: as in any other medium, companies can communicate only non-promotional information about products to the public, and only in response to a direct inquiry. However, the guidance does suggest that companies could post more basic product info on their websites.
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.